Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Every figure this model derived for CRBP, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2022-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 117,941,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 122,753,000 AssetsCurrent 2026-06-30
current liabilities 21,483,000 LiabilitiesCurrent 2026-06-30
equity 102,240,000 StockholdersEquity 2026-06-30
revenue 0 RevenueFromContractWithCustomerExcludingAssessedTax 2022-12-31
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CRBP on one particular measure came for.

RatioValue
current ratio5.71
current ratio reported5.71
growth cv2.98
revenue growth-100.0
revenue growth per share-100.0

What to be careful about

What this model itself distrusts about CRBP's figures. Written by the derivation as it ran, not added afterwards.